Unlock instant, AI-driven research and patent intelligence for your innovation.

Use of SLC 19A3 gene

A 1. SLC19A3, gene technology, applied in the field of medicine and biology

Inactive Publication Date: 2011-08-10
HANGZHOU BOPU MEDICAL TECH
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Human SLC19A3 gene (solute carrier family 19 member 3) (Genbank No. NM_025243.3), also known as Thiamine transporter 2 (ThTr-2), is a transmembrane transporter, and its relationship with tumorigenesis is not yet clear, and further research is needed

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Use of SLC 19A3 gene
  • Use of SLC 19A3 gene
  • Use of SLC 19A3 gene

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0027] Example 1 RT-PCR experiment to detect the expression of SLC19A3 gene in tumor cells

[0028] 1. Cell culture

[0029] All cells were cultured in RPMI-1640 medium containing 100 U / ml penicillin, 100 μg / ml streptomycin and 10% FBS at 37°C in 5% CO 2 cultured in an incubator.

[0030] 2. Total RNA extraction kit

[0031] The total RNA of cells was isolated and extracted with Trizol reagent from Invitrogen Company according to the method provided by the manufacturer. The reagent is produced based on one-step extraction with acidic phenols. The utensils and water used for RNA extraction must be RNase-free to ensure an RNase-free environment in the experiment.

[0032] 3. Extraction of total RNA

[0033] Cultivate the cells to the logarithmic growth phase, drain the culture medium, add 1ml Trizol directly, let stand at room temperature for 5 minutes, and collect the cells into a 1.5ml centrifuge tube. After adding chloroform, centrifuge at 4oC to separate layers; tran...

Embodiment 2

[0050] Example 2 Real-time quantitative PCR experiment to detect the expression of SLC19A3 gene in tumor tissue

[0051] 1. Tissue Isolation

[0052] All specimens were pathologically confirmed. Once the surgically resected specimens are removed from the body, the tumor lesions and adjacent tissues are quickly excised and stored in liquid nitrogen.

[0053] 2. Total RNA extraction

[0054] Dry-bake the homogenizer at 200oC for 4 hours to remove RNase and cool down; take the tissue out of the liquid nitrogen quickly and grind it into powder; use a spatula to put the tissue into the homogenizer pre-added with TRIzol reagent, and homogenize A few minutes; transfer the homogenized liquid into an RNase-free centrifuge tube, add chloroform, and centrifuge at 4oC to separate layers; transfer the upper aqueous phase to an RNase-free centrifuge tube, add isopropanol, and centrifuge at 4oC Precipitate RNA; wash the pellet twice with 75% ethanol; air-dry and dissolve the pellet in R...

Embodiment 3

[0060] Example 3 Cloning of SLC19A3 cDNA and construction of expression vector

[0061] 1. Synthesis of clone-specific cDNA

[0062] The reverse transcription reaction (RT) used the SuperScript III First Synthesis System for RT-PCR kit from Invitrogen, USA, and 2 micrograms of total RNA was used in each reaction. The total reaction volume is 20 microliters: 2 microliters of 10×RT buffer, 5 microliters of total RNA, 1 microliter of OligodT20 primer, 1 microliter of 10mM dNTP, 4 microliters of 25mM MgCl2, 1 microliter of 0.1M DTT, 1 microliter of RNaseOUT , SuperScript III reverse transcriptase 1 microliter, high-purity deionized water 4 microliters. The reverse transcription reaction was performed using an ABI PCR instrument, and the specific operating parameters were as follows: 10 minutes at 25oC; 120 minutes at 37oC; 5 minutes at 85oC; and cool to 4oC. Store at -20oC for later use. 50oC for 50 minutes, 85oC for 5 minutes, add RNaseH after cooling to 4oC, and incubate at...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the technical field of medical biology, in particular the use of a novel cancer suppressor gene, namely the SLC 19A3 gene, in the preparation of medicines for diagnosing, preventing and treating tumors. The cancer suppressor gene can specifically expressed on a low level in tumor cells and tumor tissues and has an effect of suppressing the growth of tumor cells; therefore, through screening tumor in which the cancer suppressor gene is expressed on a low level and specifically restoring the expression of the cancer suppressor gene in the tumor cells, a new method is provided for tumor targeted treatment.

Description

technical field [0001] The invention relates to the field of medical biotechnology, in particular to the application of a new tumor suppressor gene SLC19A3 gene in the preparation of drugs for tumor diagnosis, prevention and treatment. Background technique [0002] Tumor development is a multi-step process, involving the activation of oncogenes and the inactivation of tumor suppressor genes. By detecting these altered oncogenes and tumor suppressor genes, the occurrence of tumors can be detected early at the molecular level, thereby creating opportunities for timely intervention. With the in-depth study of tumors, the diagnosis and clinical treatment of tumors have begun to be carried out at the molecular level. Through techniques such as PCR and proteomics, the development of new tumor-related markers is increasing the level of early diagnosis of tumors. Early diagnosis and early treatment are the key to improving the cure rate of tumors. At the same time, on the basis o...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61P35/02A61K48/00C12Q1/68
Inventor 王娴金洪传冯利锋吴启安
Owner HANGZHOU BOPU MEDICAL TECH